Efficacy of Tezepelumab in Patients With Evidence of Severe Allergic Asthma: Results From the Phase 3 NAVIGATOR Study. Bank MJ, Wall LA. Pediatrics 2023;152.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bank MJ, Wall LA. Efficacy of Tezepelumab in Patients With Evidence of Severe Allergic Asthma: Results From the Phase 3 NAVIGATOR Study. Pediatrics 2023;152.
PMID: 38038569